Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 8944007)

Published in J Natl Cancer Inst on December 04, 1996

Authors

R Heimann1, D Ferguson, C Powers, W M Recant, R R Weichselbaum, S Hellman

Author Affiliations

1: Department of Radiation and Cellular Oncology, Pritzker School of Medicine, University of Chicago, IL 60637, USA.

Articles citing this

Intra-tumoural microvessel density in human solid tumours. Br J Cancer (2002) 1.60

Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. Am J Pathol (2012) 1.45

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer (1998) 1.38

Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol (2003) 1.32

Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer (1998) 1.25

Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer. Virchows Arch (2004) 1.16

Potential angiogenic role of platelet-activating factor in human breast cancer. Am J Pathol (1998) 1.11

The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer. Br J Cancer (2003) 1.09

Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ. Br J Cancer (2005) 0.98

Vascular grading of angiogenesis: prognostic significance in breast cancer. Br J Cancer (2000) 0.95

Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer. Br J Cancer (2001) 0.86

Microvessel density and status of p53 protein as potential prognostic factors for adjuvant anthracycline chemotherapy in retrospective analysis of early breast cancer patients group. Pathol Oncol Res (2012) 0.81

Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation. Clin Exp Metastasis (1998) 0.79

Shrimp lipids: a source of cancer chemopreventive compounds. Mar Drugs (2013) 0.79

Vascular endothelial growth factor overproduced by tumour cells acts predominantly as a potent angiogenic factor contributing to malignant progression. Int J Exp Pathol (1999) 0.78

Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures. Breast Cancer Res (2015) 0.77

Thymidine phosphorylase expression and stromal vascularity in ductal carcinoma in situ of the breast. J Clin Pathol (2003) 0.76

Articles by these authors

The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther (2000) 13.16

Head and neck cancer. N Engl J Med (1993) 6.33

Oligometastases. J Clin Oncol (1995) 4.95

Current perspectives on the epidemiology and pathogenesis of clinically significant Vibrio spp. Clin Microbiol Rev (1988) 4.76

The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem (2000) 4.49

VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest (2000) 4.36

Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res (1999) 4.17

Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol (2000) 3.39

Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr (1989) 3.12

A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol (1989) 2.71

Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature (1995) 2.54

Radiation therapy of early carcinoma of the breast without mastectomy. Cancer (1980) 2.49

Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer. Int J Radiat Oncol Biol Phys (1995) 2.45

Xrcc3 is required for assembly of Rad51 complexes in vivo. J Biol Chem (1998) 2.44

Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. J Clin Microbiol (1993) 2.33

Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature (1998) 2.29

Diagnosis and natural history of extramammary tumors metastatic to the breast. J Am Coll Surg (1994) 2.17

Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther (1995) 2.11

Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys (1979) 2.10

SimulFluor respiratory screen for rapid detection of multiple respiratory viruses in clinical specimens by immunofluorescence staining. J Clin Microbiol (2000) 2.10

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol (2003) 2.09

Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer (1993) 2.07

Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res (2000) 2.06

Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci U S A (1989) 2.05

Stopping metastases at their source. N Engl J Med (1997) 2.03

Communication skills in veterinary education. J Am Vet Med Assoc (1994) 2.01

The GLN3 gene product is required for transcriptional activation of allantoin system gene expression in Saccharomyces cerevisiae. J Bacteriol (1990) 1.98

Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer (1984) 1.95

Defective embryonic neurogenesis in Ku-deficient but not DNA-dependent protein kinase catalytic subunit-deficient mice. Proc Natl Acad Sci U S A (2000) 1.90

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol (1990) 1.90

Impact of sample type on rapid detection of influenza virus A by cytospin-enhanced immunofluorescence and membrane enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 1.86

Hodgkin's disease: evidence for a tumor-associated antigen. N Engl J Med (1971) 1.83

Parameters affecting the frequencies of transformation and co-transformation with synthetic oligonucleotides in yeast. Yeast (1992) 1.81

p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res (1993) 1.80

Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am (1997) 1.80

Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol (2000) 1.78

Pathogenesis of Hodgkin's disease. Lancet (1972) 1.77

Restructuring the neuronal stress response with anti-glucocorticoid gene delivery. Nat Neurosci (2004) 1.72

The disappearance of cyclins A and B and the increase in activity of the G(2)/M-phase cellular kinase cdc2 in herpes simplex virus 1-infected cells require expression of the alpha22/U(S)1.5 and U(L)13 viral genes. J Virol (2000) 1.70

Emergence of a restricted bioserovar of Vibrio parahaemolyticus as the predominant cause of Vibrio-associated gastroenteritis on the West Coast of the United States and Mexico. J Clin Microbiol (1989) 1.68

Effect of delayed specimen processing on cytomegalovirus antigenemia test results. J Clin Microbiol (1995) 1.66

Proliferative capacity of murine hematopoietic stem cells. Proc Natl Acad Sci U S A (1978) 1.62

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Spatial and temporal control of gene therapy using ionizing radiation. Nat Med (1995) 1.59

Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke (1998) 1.59

Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol (1995) 1.59

Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol (1989) 1.57

Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res (2000) 1.55

Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status. Cancer J Sci Am (2006) 1.54

The essential functions of human Rad51 are independent of ATP hydrolysis. Mol Cell Biol (1999) 1.51

Nasopharyngeal carcinoma. Lancet (1997) 1.51

Considerations in the radiation therapy of Wilms' tumor. Cancer (1973) 1.51

Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci U S A (1986) 1.51

Race and the Will Rogers phenomenon in prostate cancer. Cancer J Sci Am (1998) 1.50

Epidemiologic investigations of Yersinia enterocolitica and related species: sources, frequency, and serogroup distribution. J Clin Microbiol (1990) 1.50

Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci U S A (1990) 1.50

Breast cancer metastatic phenotype as predicted by histologic tumor markers. Cancer J Sci Am (1997) 1.48

Limited surgery and radiotherapy for early breast cancer. N Engl J Med (1985) 1.48

Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype. Mol Med (2002) 1.47

Toxoplasma gondii--keeping our guests under control. Biologist (London) (2000) 1.47

Detection of herpes simplex virus in clinical specimens by cytospin-enhanced direct immunofluorescence. J Clin Microbiol (1997) 1.45

Loss of hematopoietic stem cell self-renewal after bone marrow transplantation. Blood (1989) 1.45

Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res (1996) 1.44

Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol (1994) 1.44

Biomechanics of slips. Ergonomics (2001) 1.44

Functional analysis of Tpr: identification of nuclear pore complex association and nuclear localization domains and a role in mRNA export. J Cell Biol (1998) 1.43

Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42

It's too soon to know. J Natl Cancer Inst (1990) 1.42

Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am (1999) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Effects of noise and noise suppression on speech perception by cochlear implant users. Ear Hear (1992) 1.40

X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res (1980) 1.40

The benefits of mammography are not limited to women of ages older than 50 years. Cancer (1998) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

The key and the lamppost. J Clin Oncol (1999) 1.39

Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease. Int J Radiat Oncol Biol Phys (1995) 1.39

Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer Invest (1995) 1.39

Advances in radiation oncology. Lancet (1997) 1.39

Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys (1994) 1.38

Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells. J Biol Chem (2001) 1.38

A piece of my mind. Tales of the unnatural: return from the dean(d) JAMA (1998) 1.38

Evidence for structured variation in self-renewal capacity within long-term bone marrow cultures. Proc Natl Acad Sci U S A (1980) 1.38

Effects of chronic restraint stress and estradiol on open field activity, spatial memory, and monoaminergic neurotransmitters in ovariectomized rats. Neuroscience (2002) 1.38

Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand (2014) 1.37

Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc Natl Acad Sci U S A (1991) 1.36

The first century of cancer chemotherapy. J Clin Oncol (1998) 1.35

Age at primary infection with Salmonella enterica serovar Typhimurium in the chicken influences persistence of infection and subsequent immunity to re-challenge. Vet Immunol Immunopathol (2004) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

The role of cdc2 in the expression of herpes simplex virus genes. Proc Natl Acad Sci U S A (2000) 1.34

Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery (1989) 1.34

Public health and brownfields: reviving the past to protect the future. Am J Public Health (1998) 1.33

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

An Australian study of telegraphists' cramp. Br J Ind Med (1971) 1.30